KMTS
Kestra Medical Technologies, Ltd. Common StockKMTS
KMTS
About: Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
–
Funds holding %
of 7,419 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$23
2%
downside
Avg. target
$27
15%
upside
High target
$29
23%
upside
5 analyst ratings
4 positive
80%
1 neutral
20%
0 negative
0%
Goldman Sachs David Roman 25% 1-year accuracy 5 / 20 met price target | 2%downside $23 | Neutral Maintained | 16 Apr 2025 |
Wolfe Research Mike Polark 50% 1-year accuracy 6 / 12 met price target | 23%upside $29 | Outperform Initiated | 31 Mar 2025 |
Wells Fargo Larry Biegelsen 24% 1-year accuracy 11 / 46 met price target | 19%upside $28 | Overweight Initiated | 31 Mar 2025 |
Stifel Rick Wise 24% 1-year accuracy 8 / 34 met price target | 19%upside $28 | Buy Initiated | 31 Mar 2025 |
Piper Sandler Matt O'Brien 32% 1-year accuracy 16 / 50 met price target | 15%upside $27 | Overweight Initiated | 31 Mar 2025 |
Financial journalist opinion
Neutral
GlobeNewsWire
2 weeks ago
Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14
KIRKLAND, Wash., April 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that it will report financial results for the third quarter fiscal 2025 on Monday, April 14. Management will host a corresponding conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time.
Neutral
GlobeNewsWire
1 month ago
Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering
KIRKLAND, Wash., March 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, announced today that the underwriters of Kestra's initial public offering exercised in full their previously disclosed over-allotment option and have purchased 1,782,352 shares of common stock at a public offering price of $17.00 per share. After giving effect to the sale of over-allotment option, the total number of shares sold by Kestra in the initial public offering was 13,664,704 and the total gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Kestra, were approximately $232 million. The issuance and sale of the over-allotment option closed today.
Positive
Seeking Alpha
1 month ago
Kestra Medical Technologies: A Potential Promising Public Offering
Kestra Medical Technologies has seen rapid growth but incurs substantial operating losses, making its valuation exercise a hard one. The company's Cardiac Recovery System, including the ASSURE WCD, addresses a significant market need for sudden cardiac arrest intervention. Despite strong product adoption and a large addressable market, risks include high losses, being a one-product business, and potential growth slowdown.
Neutral
GlobeNewsWire
1 month ago
Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering
KIRKLAND, Wash., March 07, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, announced today the closing of its upsized initial public offering of 11,882,352 common shares at a public offering price of $17.00 per share. The total gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Kestra, were approximately $202 million. All of the common shares were offered by Kestra. Kestra's common shares began trading on the Nasdaq Global Select Market on March 6, 2025, under the ticker symbol "KMTS".
Positive
GeekWire
1 month ago
Kestra Medical Technologies raises $202M in IPO, prices shares above expected range
Kirkland, Wash.-based Kestra Medical Technologies raised $202 million in its initial public offering, pricing shares at $17.
Neutral
GlobeNewsWire
1 month ago
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering
KIRKLAND, Wash., March 05, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the pricing of its upsized initial public offering of 11,882,352 common shares at a public offering price of $17.00 per share.
Neutral
Seeking Alpha
1 month ago
U.S. IPO Weekly Recap: Small Asia-Based Names List, As TV Adtech MNTN And Others Join The Pipeline
Four IPOs and four SPACs listed this week. Four IPOs and two SPACs submitted initial filings. The March IPO market is set to start off with a quiet week.
Positive
GeekWire
1 month ago
Kestra Medical Technologies aims to raise $150M in IPO
Kirkland, Wash.-based Kestra Medical Technologies is aiming to raise about $150 million in its initial public offering, pricing shares between $14 and $16 on the Nasdaq, according to a new regulatory filing.
Neutral
GlobeNewsWire
1 month ago
Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering
KIRKLAND, Wash., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the launch of its initial public offering of 10,000,000 common shares.
Neutral
Seeking Alpha
1 month ago
U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small Listings
The calendar slowed down this past week, with only small listings in the US. There was one sizable filing this past week - AIRO Group Holdings. No IPOs are currently scheduled to list in the week ahead, although some small deals may list throughout it.
Charts implemented using Lightweight Charts™